Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Systemic diseases can cause hair loss, which is often reversible with treatment.

More research is needed to find a cure for hair loss after pregnancy.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Children's screen time increased during the pandemic, causing various health issues.

Nursing staff's mental health was affected during the COVID-19 pandemic.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Latanoprost can make eyelashes longer, thicker, and darker.

Crash dieting can cause hair loss due to severe calorie restriction.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Topical Minoxidil is effective for hair loss after COVID-19.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.